Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
0.8050
-0.0537 (-6.25%)
At close: Nov 20, 2026, 4:00 PM EST
0.8104
+0.0054 (0.67%)
After-hours: Nov 20, 2026, 7:30 PM EST
Nyxoah Employees
Nyxoah had 154 employees as of December 31, 2025. The number of employees decreased by 30 or 16.29% compared to the previous year.
Employees
154
Change (1Y)
-30
Growth (1Y)
-16.29%
Revenue / Employee
$213,235
Profits / Employee
-$666,799
Market Cap
83.64M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 154 | -30 | -16.29% |
| Dec 31, 2024 | 184 | 37 | 25.07% |
| Dec 31, 2023 | 147 | 9 | 6.76% |
| Dec 31, 2022 | 138 | 32 | 29.96% |
| Dec 31, 2021 | 106 | 34 | 47.15% |
| Mar 31, 2021 | 79 | 36 | 84.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Neuronetics | 658 |
| Quanterix | 450 |
| Pulmonx | 296 |
| Apyx Medical | 205 |
| Perspective Therapeutics | 166 |
| LENSAR | 150 |
| Owlet | 114 |
| TriSalus Life Sciences | 102 |
NYXH News
- 4 days ago - Nyxoah obtains default decision against Inspire Medical in UPC in Munich - TheFly
- 4 days ago - Nyxoah Obtains Default Decision Against Inspire Medical Systems in Unified Patent Court Case - GlobeNewsWire
- 16 days ago - Nyxoah reports Q3 EPS (EUR 0.18), consensus (EUR 0.32) - TheFly
- 16 days ago - Nyxoah backs FY26 revenue view EUR 33M-EUR 35M, consensus EUR 34.77M - TheFly
- 16 days ago - Nyxoah Earnings Call Transcript: Q3 2026 - Transcripts
- 16 days ago - Nyxoah Earnings release: Q3 2026 - Filings
- 26 days ago - Nyxoah price target lowered to $3 from $6 at Cantor Fitzgerald - TheFly
- 26 days ago - Nyxoah to Release Third Quarter 2026 Financial Results on November 5, 2026 - GlobeNewsWire